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Abstract Hypercellularity and accumulation of extracellular
matrix are common responses of renal glomeruli to inflammatory
stimuli. Using the differential display approach, we compared the
gene expression patterns of proliferating and differentiating rat
mesangial cells in two- and three-dimensional cultures. Osteo-
pontin, an extracellular matrix protein, was found to be
transcribed, synthesized, and secreted by rat mesangial cells.
Osteopontin transcription was not associated with cell prolifera-
tion and was found to be FCS-inducible in proliferating cells.
Osteopontin expression was independent of exogenously supplied
FCS in differentiating cells. The presented data indicate that
osteopontin is differentially regulated in proliferating and
differentiating mesangial cells.
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1. Introduction
Renal mesangial hypercellularity plays an important patho-
genic role in glomerular injury. Previous studies have demon-
strated speci¢c e¡ects of soluble factors and extracellular ma-
trix components on the mesangial cell phenotype in vivo and
in vitro [1^3].
We hypothesize that signals arising from the interaction
between mesangial cells, matrix molecules, and soluble factors
¢nally lead to the induction or suppression of genes which
control mesangial cell proliferation. We intended to identify
genes which were regulated when the mesangial cell phenotype
changed from a mitotically quiescent to a proliferative one. As
experimental model, we used the three- (3D-) and two-dimen-
sional (2D-) culture systems. As previously shown, cultured
rat mesangial cells embedded within a 3D-collagen I gel ex-
hibited a quiescent and di¡erentiated cell phenotype, closely
resembling the phenotype observed in vivo in healthy glomer-
uli [4,5]. In 2D-culture mesangial cells proliferated, thus re-
sembling a phenotype observed in vivo in glomerular diseases
[2,6,7].
Employing the di¡erential display strategy [8], we compared
the gene expression patterns of these two di¡erent mesangial
cell phenotypes at various time points. We identi¢ed osteo-
pontin, an extracellular matrix protein, that was dramatically
downregulated in proliferating cells. In this study we investi-
gated osteopontin expression at the mRNA and protein level
in more detail.
2. Materials and methods
2.1. Cell culture
Rat mesangial cells were obtained and cultured as previously de-
scribed [4,9]. Cells between the 10th and 19th passage were used for
the experiments.
Collagen type I substrate for 2D- and 3D-cultures: Acid-soluble
collagen type I was isolated from fetal calf skin and puri¢ed as pre-
viously described [10].
For experiments in 2D-culture dishes were coated overnight at 4‡C
with 12.5 Wg/ml type I collagen dissolved in PBS. 16 000 cells/cm2 were
seeded per dish, cultured in 10% FCS-containing DMEM and har-
vested for RNA extraction at the time points indicated.
For experiments in 3D-culture, type I collagen was solubilized at
4‡C in 100 mM acetic acid to achieve a ¢nal concentration of 1.25 mg/
ml. Solubilized collagen I was mixed with one tenth of 10UEarle’s salt
(Life Technologies, Eggenstein, Germany) and neutralized with sterile
sodium hydroxide (1 M). Cells were added to achieve a ¢nal concen-
tration of 106 cells/ml neutralized collagen. Polymerized collagen gels
were supplied with 10% FCS-containing DMEM.
2.2. RNA isolation and Northern blotting
Total RNA was isolated according to Chomczynski and Sacchi [11].
For RNA extraction of cells in 3D-culture, the cell-containing gels
were shock-frozen in liquid nitrogen, ground and dissolved in 4 M
guanidinium thiocyanate. 10 Wg total RNA was loaded per lane onto
formaldehyde-containing agarose gels (1.2%). Northern blotting was
performed as described [12]. All experiments were done at least twice.
2.3. Di¡erential display and sequencing
Di¡erential display was performed according to the protocol pub-
lished by Liang and Pardee [8] as described before [12]. PCRs were
performed using 5 WM 3P-primer (dT10MA) and 2 WM 5P-primer (5P-
TCGATACATG-3P) as primer pair [12]. Fragments of interest were
isolated, reampli¢ed, and subcloned into the SrfI site of pCR-Script
cloning vector (Stratagene, Heidelberg, Germany).
Sequence analysis was performed according to Sanger et al. [13]
using a T7-polymerase kit (Pharmacia, Freiburg, Germany).
2.4. Immunocytochemistry
For double staining of the Thy1.1 antigen and the osteopontin
protein in 2D-culture, 10 000 cells were seeded into chamber slides
and grown in 10% FCS-containing DMEM for 24 h. After washing,
the cells were incubated in 50 mM ammonium chloride, permeabilized
in 0.2% (v/v) Triton X-100, and blocked with FCS. The primary anti-
bodies anti-osteopontin (rabbit anti-rat, diluted 1:500) and the anti-
Thy1.1 antibody (mouse anti-rat, 1:1000) were added simultaneously,
detected by incubation with DTAF-conjugated goat anti-rabbit and
Cy3-conjugated sheep anti-mouse secondary antibodies, and visual-
ized by £uorescence microscopy. For osteopontin staining in 3D-cul-
ture, 200 Wl of the cell-containing collagen I was transferred into
chamber slides and cultured in 10% FCS-containing medium for 24
h. These 3D-gels were incubated with anti-Thy1.1 antibody, and the
Thy1.1 antigen was detected with DTAF-conjugated goat anti-rabbit
secondary antibody. The polyclonal osteopontin antibody was kindly
provided by A. Beshensky and J.G. Kleinman (Veterans A¡airs Med-
ical Center, Division of Nephrology, Milwaukee, WI, USA). The
monoclonal antibody ox-7, which recognizes the Thy1.1 epitope,
was purchased from Pharmingen (San Diego, CA, USA).
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2.5. Western blot analysis
Protein extraction: Cells grown in 2D-culture were harvested by
scraping them o¡ the dishes. From cells cultured in 3D-culture, gels
were shock-frozen in liquid nitrogen, ground and extracted in lysis
bu¡er. To purify secreted osteopontin from the medium, cells were
grown to con£uence in 10% FCS-containing DMEM and then incu-
bated in serum-free DMEM for 48 h. The DMEM was collected and
osteopontin was pelleted in the cold with 0.38% sodium citrate and
1.5% barium chloride. After centrifugation, the pellet was washed in
1.5% barium chloride and dissolved in 0.2 M sodium citrate (pH 6.8).
Protein gels and immunostaining were performed as described previ-
ously [12]. Equal loading of cellular protein per lane was con¢rmed
using Ponceau dye (Sigma Aldrich Chemical Co., Deisenhofen, Ger-
many). Three series of independent experiments were done.
3. Results
3.1. Identi¢cation of di¡erentially expressed genes
To investigate gene expression in proliferating and termi-
nally di¡erentiating rat mesangial cells, RNA was extracted
from cells in 2D-culture 3 days after seeding and from cells
subjected to 3D-culture after 6, 12, 24, 48, and 72 h. Di¡er-
ences in the gene expression patterns were analyzed by the
di¡erential display method. With the employed primer pair
two di¡erentially expressed mRNA species were identi¢ed.
One of them exhibited low expression in 2D-culture and
high expression in 3D-culture (data not shown). Sequence
analysis of this clone showed 99.1% sequence homology
over a stretch of 247 bp in the 3P untranslated region to rat
osteopontin [14]. Osteopontin expression was veri¢ed by
Northern blot analysis. Osteopontin mRNA was initially
high in 2D- and 3D-culturesY. In 2D-culture it was rapidly
downregulated with lowest expression after 72 h when the
cells became almost con£uent. In 3D-culture, osteopontin
mRNA levels remained unaltered at high expression level up
to 72 h. (Fig. 1a).
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Fig. 1. Northern blot analysis of the osteopontin expression in rat mesangial cells. RNA was isolated at the time points indicated and hy-
bridized with 32P-labeled osteopontin and 18S cDNA probes (a^d). a: Cells were cultured in 2D- and 3D-cultures in the presence of 10% FCS.
b: Con£uent mesangial cells were trypsinized (Co) and plated at two di¡erent densities: 1U106 cells/dish (16 000 cells/cm2) and 6U106 cells/
dish (94 500 cells/cm2). c: Con£uent mesangial cells were trypsinized (Co) and 1U106 cells were plated per dish. (*) Medium was changed after
66 h, the cells were grown for another 6 h and harvested after a total of 72 h. d: Cells in 3D-culture were supplied with fresh 10% FCS-con-
taining medium on days 1, 3, and 5.
Fig. 2. Immunocytochemical detection of osteopontin in mesangial cells. Double-staining of the same cell with anti-Thy1.1-antibody speci¢c for
rat mesangial cells (a) and the osteopontin antibody in 2D-culture (b). Osteopontin staining of mesangial cells cultured in 3D-culture for 24
hours (c). Magni¢cation 350U.
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3.2. Osteopontin expression in 2D-culture is induced by FCS
irrespective of cell-cell contacts and proliferation rates
As shown in Fig. 1a, osteopontin mRNA levels declined
with ongoing culturing time in proliferating cells. We inves-
tigated whether downregulation of osteopontin expression
was linked to increasing numbers of cell-cell contacts. Mesan-
gial cells were plated at low (106 cells/90 mm dish) and high
(6U106 cells/90 mm dish corresponding to con£uence) cell
densities and osteopontin expression was assessed up to 48
h. Northern blot analysis showed that the osteopontin expres-
sion patterns were comparable, irrespective of the initial cell
densities (Fig. 1b). Counting the cells revealed that the cell
number had increased ¢ve-fold within 72 h when cells were
plated at low density. There was a 1.3-fold increase when cells
were plated at high density. These data indicated that osteo-
pontin expression did not correlate with cellular proliferation.
To investigate whether osteopontin in 2D-culture was FCS-
inducible, mesangial cells were plated at low density and har-
vested at the time points indicated (Fig. 1c). After 66 h, the
culture medium was changed, the cells incubated for another
6 h with fresh medium containing 10% FCS, and harvested
after a total of 72 h. Northern blot analysis showed that
osteopontin expression could be reinduced by FCS (Fig. 1c).
3.3. Osteopontin expression in 3D-culture is independent of
FCS
We investigated osteopontin expression in 3D-culture up to
9 days by changing the medium every second day (Fig. 1d) or
once after 3 days (data not shown). Osteopontin mRNA levels
were identical under both experimental conditions. Until the
¢fth day of 3D-culture, the levels were elevated, and they
decreased after 7 and 9 days (Fig. 1d). Since this expression
pattern was irrespective of medium changes, the data suggest
that osteopontin expression was not FCS-inducible in 3D-cul-
ture.
3.4. Osteopontin protein expression in mesangial cells
Immunocytochemical analysis showed perinuclear localiza-
tion of the osteopontin protein in 2D- (Fig. 2b) and in 3D-
culture (Fig. 2c). The antigen Thy1.1 is a speci¢c marker of
rat mesangial cells [15]. By double-staining the cells with anti-
Thy1.1 and osteopontin antibody, we could clearly show that
osteopontin was synthesized in rat mesangial cells (Fig. 2a,b).
Western blot analysis showed three major osteopontin pro-
tein bands of about 34, 36, and 62 kDa in proliferating cells.
While the 36 and 62 kDa bands remained at a comparable
level from 6 to 72 h, the 34 kDa band increased after 48 and
72 h (Fig. 3, lanes 1^5). A 62 kDa osteopontin form was
isolated from the medium of con£uent mesangial cells (Fig.
3, lane 6). When the cells were subjected to 3D-culture, the
discrete 62 kDa band was no longer detectable. Instead, pro-
tein labeling was observed as a bulk ranging from 50 kDa to
75 kDa, possibly due to posttranslational modi¢cations. The
34 and 36 kDa bands remained clearly visible with increasing
36 kDa protein concentrations. A novel 38 kDa band ap-
peared from 48 h 3D-culture onwards (Fig. 3, lanes 7^12).
4. Discussion
The aim of this study was to identify genes that were spe-
ci¢cally induced or suppressed when the mesangial cell phe-
notype changed from a mitotically quiescent one in 3D-cul-
ture to the proliferative one in 2D-culture. Previous work has
shown that mesangial cells and cells derived from di¡erent
organ systems di¡erentiated and maintained a phenotype
closely related to the normal in vivo phenotype when sub-
jected to 3D-culture [4,10,16^21]. Using the di¡erential dis-
play strategy, we compared the gene expression patterns of
both phenotypes and succeeded in identifying osteopontin as a
di¡erentially expressed mRNA transcript.
Osteopontin is a secreted extracellular matrix protein,
which has been reported to be expressed in a variety of
di¡erent cell types [22]. In healthy kidneys osteopontin is se-
creted into the tubule £uid [23], where it presumably inhibits
renal stone formation [24,25]. Only very recently, osteopontin
has also been shown to be expressed in rat mesangial cells
[26]. Thus, besides the inhibition of stone formation, osteo-
pontin might exert additional functions in the nephritic kid-
ney.
We therefore analyzed the osteopontin expression pattern
at the RNA and protein levels in more detail. Osteopontin
mRNA levels were initially high when cells were plated in 2D-
culture and declined gradually over days. Osteopontin expres-
sion was shown to be independent of the cell density and
proliferation rate, but was induced and reinducible by FCS.
In 3D-culture, osteopontin expression could not be reinduced
by FCS addition. These data indicate that proliferating and
quiescent cells respond in a di¡erentiated manner to external
stimuli.
Although not inducible by FCS, osteopontin mRNA levels
in 3D-culture remained high for a prolonged period and de-
clined only after 7^9 days. This suggests that either not yet
identi¢ed stimuli of the surrounding matrix induced osteopon-
tin mRNA and kept it at the elevated level, or that osteopon-
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Fig. 3. Western blot analysis of osteopontin protein in 2D- and 3D-cultures. Protein was isolated from proliferating cells (2D-culture, lanes 1^
5) and from terminally di¡erentiating cells (lanes 7-11) at the time points indicated. Secreted osteopontin protein was isolated from conditioned,
serum-free medium of con£uent cells (2D-culture, lane 6). Cell-free collagen gels cultured in medium for 72 h served as control (Co).
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tin mRNA is stabilized in 3D-culture whereas non-stabilized
RNA in 2D-culture decreased within 72 h.
Immunoblotting revealed four distinct osteopontin protein
species of di¡erent sizes. Since Northern blot analysis showed
a unique osteopontin mRNA band, we assume that the var-
ious protein bands were due to posttranslational modi¢cations
[22]. In 2D-culture, osteopontin RNA decreased while the
protein concentration increased, suggesting that the protein
was processed and continuously accumulated while the
RNA was degraded. The distinct 62 kDa protein band, syn-
thesized in 2D-culture, could not be visualized in 3D-culture.
Instead, the protein bulk above stained stronger, which could
be due to increasing posttranslational modi¢cations or bind-
ing of the secreted osteopontin to other proteins. According to
the time course of protein synthesis, we assume that the 62
kDa osteopontin protein is the synthesized ^ as well as the
secreted ^ form, whereas the 34, 36, and 38 kDa species could
be proteolytic cleavage products [22].
In conclusion, the presented data show that osteopontin is
synthesized and secreted by rat mesangial cells in vitro. The
mRNA expression pattern, the corresponding protein pro¢le
and the transcriptional regulation of osteopontin mRNA ex-
pression are clearly distinct in proliferating and terminally
di¡erentiating cells. This suggests that the deposition of the
extracellular matrix protein osteopontin might be of function-
al importance for the modulation of the mesangial cell phe-
notype.
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